D
Denali Therapeutics Inc. DNLI
$15.15 $0.261.75%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 09/30/2024
Revenue -- --
Total Other Revenue -- --
Total Revenue -- --
Cost of Revenue 1.58% 583.92%
Gross Profit -1.58% -583.92%
SG&A Expenses 20.48% -0.97%
Depreciation & Amortization -- --
Other Operating Expenses -- --
Total Operating Expenses 5.41% 5.66%
Operating Income -5.41% -5.66%
Income Before Tax -6.99% -8.25%
Income Tax Expenses -- --
Earnings from Continuing Operations -7.05% -8.25%
Earnings from Discontinued Operations -- --
Extraordinary Item & Accounting Change -- --
Minority Interest in Earnings -- --
Net Income -7.05% -8.25%
EBIT -5.41% -5.66%
EBITDA -7.16% -5.47%
EPS Basic -6.66% -7.86%
Normalized Basic EPS -12.32% -7.86%
EPS Diluted -6.66% -7.22%
Normalized Diluted EPS -12.32% -7.86%
Average Basic Shares Outstanding 0.37% 0.37%
Average Diluted Shares Outstanding 0.37% 0.37%
Dividend Per Share -- --
Payout Ratio -- --
Weiss Ratings